Another under-$10 name that???s starting to trend into range of triggering a near-term breakout trade is Xoma (XOMA), which is engaged in the discovery, development and manufacture of therapeutic antibodies and other agents designed to treat inflammatory, autoimmune, infectious and oncological diseases.